Brief: Astrazeneca Pharma India Says MD Gagandeep Singh Bedi Resigns
14/12/2022 13:57
Dec 14 (Reuters) - Astrazeneca Pharma India Ltd
ASTR.NS :
* MD GAGANDEEP SINGH BEDI RESIGNS
* SANJEEV PANCHAL NAMED MD
Source text for Eikon: ID:nBSE9F5dt7
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan